We are live on ! Find out more
FBIO icon

Fortress Biotech
FBIO

39 hedge funds and large institutions have $16.3M invested in Fortress Biotech in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $710K | Put options by funds: $442K

3% more capital invested

Capital invested by funds: $15.9M → $16.3M (+$399K)

19% less funds holding

Funds holding: 48 → 39 (-9)

59% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 17

69% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 13

Holders
39
Holders Change
-9
Holders Change %
-18.75%
% of All Funds
1.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
17
Closed
13
Calls
$710K
Puts
$442K
Net Calls
+$268K
Net Calls Change
-$42K

Top Buyers

1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$387K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$141K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$123K
4
PPA
Parametric Portfolio Associates
Washington
+$111K
5
Goldman Sachs
Goldman Sachs
New York
+$64K

Top Sellers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$611K
2
Renaissance Technologies
Renaissance Technologies
New York
-$595K
3
Morgan Stanley
Morgan Stanley
New York
-$392K
4
Northern Trust
Northern Trust
Illinois
-$389K
5
PP
Paloma Partners
Connecticut
-$255K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$77K – – –
EEG
27
E.E. Geduld
$53K -$44.2K -1,666 -50%
State Street
28
State Street
Massachusetts
$28K – – –
LP
29
LMR Partners
United Kingdom
$22K -$165K -6,229 -90%
BGA
30
Belmont Global Advisors
Texas
$21K +$17.7K +667 New
BIM
31
BlackRock Investment Management
Delaware
$11K -$80 -3 -0.9%
DAM
32
Delta Asset Management
Tennessee
$11K – – –
Ameriprise
33
Ameriprise
Minnesota
$4K -$5.31K -200 -59%
HCC
34
Hirtle Callaghan & Co
Pennsylvania
$4K – – –
EWM
35
Edge Wealth Management
New York
$3K – – –
WA
36
WFG Advisors
Texas
$1K – – –
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$183 -$80 -3 -33%
Manulife (Manufacturers Life Insurance)
38
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2 – – –
PP
39
Paloma Partners
Connecticut
– -$255K -9,882 Closed
COPPSERS
40
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$171K -6,615 Closed
CS
41
Credit Suisse
Switzerland
– -$102K -3,947 Closed
VKH
42
Virtu KCG Holdings
New York
– -$60K -2,308 Closed
SFM
43
Soros Fund Management
New York
– -$50K -1,952 Closed
AQR Capital Management
44
AQR Capital Management
Connecticut
– -$49K -1,907 Closed
JG
45
Jefferies Group
New York
– -$32K -1,250 Closed
GC
46
Guggenheim Capital
Illinois
– -$29K -1,107 Closed
BA
47
BlackRock Advisors
Delaware
– -$25K -984 Closed
TRCT
48
Tower Research Capital (TRC)
New York
– -$18K -661 Closed
Citadel Advisors
49
Citadel Advisors
Florida
– -$12K -454 Closed
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
– -$2K -59 Closed
1
2
3

FBIO Hedge Fund Activity: Q3 2014 in Review

39 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q3 2014, worth a combined $16.3M — up 2.5% from $15.9M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of FBIO and 4 opened new positions — a net loss of 9 holders — while 17 trimmed existing stakes and 7 added.

The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $387K. The largest seller was Susquehanna International Group, cutting an estimated $611K.

  • 39 institutional investors held Fortress Biotech (FBIO) as of Q3 2014, down from 48 in Q2 2014.
  • Funds reported $16.3M of Fortress Biotech stock for Q3 2014, up 2.5% quarter-over-quarter.
  • 4 funds opened new Fortress Biotech positions in Q3 2014 and 13 closed out, a net change of -9 holders.
  • The largest Fortress Biotech buyer in Q3 2014 was Hudson Bay Capital Management, an estimated $387K added.
  • The largest Fortress Biotech seller in Q3 2014 was Susquehanna International Group, an estimated $611K sold.

Based on aggregated 13F filings for Q3 2014.